Publicacións en colaboración con investigadores/as de Universidad de Cantabria (39)

2024

  1. Calidad asistencial y heridas crónicas

    Atención integral de las heridas crónicas (Elsevier), pp. 125-131

  2. Cancer patients evaluated by the Intensive Care Unit. Predictive factors of mortality at 3 months

    Acta Colombiana de Cuidado Intensivo, Vol. 24, Núm. 3, pp. 198-207

2016

  1. Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: The Bacteraemia-MIC project

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 2, pp. 521-530

2012

  1. Anti-TNF-alpha-adalimumab therapy is associated with persistent improvement of endothelial function without progression of carotid intima-media wall thickness in patients with rheumatoid arthritis refractory to conventional therapy

    Mediators of Inflammation, Vol. 2012

2011

  1. Analysis of the influence of the ghrelin receptor rs509035, rs512692 and rs2922126 polymorphisms in the risk of cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology

  2. Audiovestibular manifestations in patients with ankylosing spondylitis

    Medicine, Vol. 90, Núm. 2, pp. 99-109

  3. Benign paroxysmal positional vertigo and clinical test of sensory interaction and balance in ankylosing spondylitis

    Otology and Neurotology, Vol. 32, Núm. 2, pp. 278-283

  4. CCR5Δ32 variant and cardiovascular disease in patients with rheumatoid arthritis: A cohort study

    Arthritis Research and Therapy, Vol. 13, Núm. 4

  5. Lack of association between ADIPOQ rs266729 and ADIPOQ rs1501299 polymorphisms and cardiovascular disease in rheumatoid arthritis patients

    Tissue Antigens, Vol. 77, Núm. 1, pp. 74-78

  6. Lack of association between LEP rs2167270 (19 G>A) polymorphism and disease susceptibility and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 2, pp. 293-298

  7. Lack of association between RETN rs1862513 polymorphism and cardiovascular disease in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 1, pp. 19-25

  8. Lack of association of NAMPT rs9770242 and rs59744560 polymorphisms with disease susceptibility and cardiovascular risk in patients with rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 29, Núm. 4, pp. 681-688

  9. Relapses and recurrences in giant cell arteritis: A population-based study of patients with biopsy-proven disease from Northwestern Spain

    Medicine, Vol. 90, Núm. 3, pp. 186-193

  10. Systemic lupus erythematosus in Northwestern Spain: A 20-year epidemiologic study

    Medicine, Vol. 90, Núm. 5, pp. 350-358

  11. TNFA -308 (rs1800629) polymorphism is associated with a higher risk of cardiovascular disease in patients with rheumatoid arthritis

    Atherosclerosis, Vol. 216, Núm. 1, pp. 125-130

  12. Vascular endothelial growth factor A and cardiovascular disease in rheumatoid arthritis patients

    Tissue Antigens, Vol. 77, Núm. 4, pp. 291-297

2010

  1. Insulin resistance in rheumatoid arthritis: The impact of the anti-TNF-α therapy: Annals of the New York Academy of Sciences

    Annals of the New York Academy of Sciences

  2. Lack of association between macrophage migration inhibitory factor-173 gene polymorphism with disease susceptibility and cardiovascular risk in rheumatoid arthritis patients from northwestern Spain

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1, pp. 68-72

  3. Lack of association of PTPN22, STAT4 and TRAF1/C5 gene polymorphisms with cardiovascular risk in rheumatoid arthritis

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 5, pp. 695-701

  4. Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy

    Clinical and Experimental Rheumatology, Vol. 28, Núm. 1, pp. 56-62